Could a single X-Ray tame COVID-19 lung inflammation?

NCT ID NCT04466683

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a single, low dose of radiation to the chest can reduce lung inflammation in hospitalized COVID-19 pneumonia patients. Researchers compare two radiation doses (35 cGy and 100 cGy) to standard care. The goal is to see if this treatment lowers the need for ventilators, shortens hospital stays, and reduces deaths.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
low-dose radiation (whole thorax radiotherapy)
What this could lead to
If it works, this could offer a simple, one-time treatment to reduce severe lung inflammation in COVID-19 pneumonia and lower the need for ventilators.
What could go wrong
This is a small, early-phase trial with only 37 participants, so results may not apply broadly. Radiation to the lungs carries unknown risks, and the treatment may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boca Raton Regional Hospital Lynn Cancer Institute

    Boca Raton, Florida, 33486, United States

  • Hospital Universitario San Ignacio

    Bogotá, Colombia

  • Indiana University School of Medicine

    Indianapolis, Indiana, 46202, United States

  • Lowell General Hospital Cancer Center

    Lowell, Massachusetts, 01854, United States

  • Loyola University Chicago

    Maywood, Illinois, 60153, United States

  • Miami Cancer Institute

    Miami, Florida, 33176, United States

  • Ohio State University James Cancer Hospital

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.